Skip to main content

Table 2 Details on recurrences and cause of death in women 18–40 years of age diagnosed with stage I epithelial ovarian cancer between 2008 and 2015

From: A Swedish Nationwide prospective study of oncological and reproductive outcome following fertility-sparing surgery for treatment of early stage epithelial ovarian cancer in young women

#

FIGO Stage

Histology

Grade

FSS

Adjuvant Chemo

Recurrence

Time to Recur. (months)

Site of Recurrence

Treatment at Recur.

Follow-Up after Recur. (months)

Status

Time from Treatment to Death (months)

Cause of Death

1

IA

Mucinous

Yes

No

Yes

18

Bone & CNS

Radiation + chemo

6

DOD

36

DOD

2

IA

LGS

Yes

No

Yes

43

Ovary

Surgery

14

NED

 

3

IC1

Mixed

1

No

No

Yes

24

Pelvic cavity

Surgery + chemo

2.5

NED

 

4

IC2

HGS

No

Yes

Yes

27

Paraaortic LN & pelvic cavity

Surgery + chemo

3

NED

 

5

IC1

CCC

No

Yes

Yes

16

Pelvic cavity

Surgery + chemo

6

AWD

 

6

IC1

CCC

No

Yes

Yes

10

Pelvic LN & pelvic cavity

Chemo

11

DOD

28

DOD

7

IA

HGS

No

Yes

Yes

26

Vaginal cuff

Surgery + chemo

10

NED

 

8

IC2

CCC

No

Yes

Yes

4.5

Peritoneal & liver

Chemo

19

DOD

30

DOD

9

IC1

Mucinous

No

Yes

No

DEAD

72

Lung cancer

10

IA

Mucinous

No

No

No

DEAD

18

Jejunal cancer

11

IC

Mucinous

No

No

No

DEAD

30

Unknown

Total, mean (range)

IA (36%)IC (64%)

     

21 (4.5–43)

  

9 (2.5–19)

 

36 (28–72)

 
  1. FSS Fertility-sparing surgery, HGS High-grade serous carcinoma, LGS Low-grade serous carcinoma, CCC Clear-cell cancer, CNS Central nervous system, LN Lymph node, NED No evidence of disease, AWD Alive with disease, DOD Died of disease